Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China · Delayed Price · Currency is CNY 6.08
-0.10 (-1.62%)
Jun 11, 2026, 11:00 AM CST
SHA:600351 Revenue
Yabao Pharmaceutical Group had revenue of 572.02M CNY in the quarter ending March 31, 2026, a decrease of -6.92%. This brings the company's revenue in the last twelve months to 2.20B, down -13.12% year-over-year. In the year 2025, Yabao Pharmaceutical Group had annual revenue of 2.24B, down -16.60%.
Revenue (ttm)
2.20B
Revenue Growth
-13.12%
P/S Ratio
1.95
Revenue / Employee
643.50K
Employees
3,415
Market Cap
4.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.24B | -445.97M | -16.60% |
| Dec 31, 2024 | 2.69B | -223.73M | -7.69% |
| Dec 31, 2023 | 2.91B | 191.63M | 7.05% |
| Dec 31, 2022 | 2.72B | -45.83M | -1.66% |
| Dec 31, 2021 | 2.76B | 161.54M | 6.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition